Isosorbide market share?

What are the current market trends for isosorbide?

Isosorbide is a vasodilator medication used in the treatment of angina and other cardiovascular conditions. According to a report by [1] IQVIA, a market research firm, isosorbide is a moderate-growth market, driven by increasing demand for treatments of cardiovascular conditions.

Who are the leading manufacturers of isosorbide?

The isosorbide market is dominated by a few key players. AstraZeneca, [2] a multinational pharmaceutical company, is a major manufacturer of isosorbide products. Other notable players in the market include Novartis and Sanofi. According to [3] DRG, these companies have a significant market share, with AstraZeneca taking the lead.

What factors are driving the growth of the isosorbide market?

The growth of the isosorbide market is driven by increasing prevalence of cardiovascular conditions, such as coronary artery disease and peripheral artery disease. Additionally, the market is expected to benefit from increasing awareness about cardiovascular health among the global population.

When does patent exclusivity expire for isosorbide products?

The patent exclusivity for isosorbide products varies by manufacturer. According to [4] DrugPatentWatch.com, several isosorbide products are facing patent expirations in the next few years, which is expected to lead to increased competition in the market and potentially lower prices.

Can biosimilars enter the market before patent expiry?

The possibility of biosimilars entering the market before patent expiry depends on various factors, including the regulatory landscape and the complexity of manufacturing processes. While no biosimilars are currently approved for isosorbide, several companies are working on developing them.

Sources:

[1] IQVIA. (2022). Isosorbide Market Report.

[2] AstraZeneca. (n.d.). Isosorbide Products.

[3] DRG. (2022). Isosorbide Market Share Report.

[4] DrugPatentWatch.com. (n.d.). Isosorbide Patent Expiration Date.